Rituximab therapy for morvan syndrome associated with myasthenia gravis

Muscle and Nerve

Volumn 46, Issue 1, 2012, Pages 139-140

  Weiss, Michael ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISONE; PYRIDOSTIGMINE; RITUXIMAB;

ADULT; AXILLARY LYMPH NODE; CASE REPORT; CEREBROSPINAL FLUID; ELECTROENCEPHALOGRAM; ELECTROMYOGRAM; FOLLICULAR HYPERPLASIA; GUILLAIN BARRE SYNDROME; HUMAN; HYPERPLASIA; INTUBATION; LETTER; LUMBAR PUNCTURE; MALE; MORVAN SYNDROME; MUSCLE DISEASE; MUSCLE TWITCH; MYASTHENIA GRAVIS; NERVE STIMULATION; PLASMAPHERESIS; PLEOCYTOSIS; PRIORITY JOURNAL; PTOSIS; RARE DISEASE; RESPIRATORY FAILURE; TREATMENT RESPONSE; WEAKNESS;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; HUMANS; IMMUNOLOGIC FACTORS; MALE; MYASTHENIA GRAVIS; SYRINGOMYELIA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84862334797     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.23311     Document Type: Letter

References (9)

1. Josephs KA, Silber MH, Fealey RD, Nippoldt TB, Auger RG, Vernino S. Neuro-physiologic studies in Morvan syndrome. J Clin Neurophysiol 2004; 21: 440-445.
2. Cornelius JR, Pittock SJ, McKeon A, Lennon VA, Aston PA, Josephs KA, et al. Sleep manifestations of voltage-gated potassium channel complex autoimmunity. Arch Neurol 2011; 68: 733-738.
3. Löscher WN, Wanschitz J, Reiners K, Quasthoff S. Morvan's syndrome: clinical, laboratory, and in vitro electrophysiological studies. Muscle Nerve 2004; 30: 157-163.
4. Liguori R, Vincent A, Clover L, Avoni P, Plazzi G, Cortelli P, et al. Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain 2001; 124( Pt 12): 2417-2426.
5. Sadnicka A, Reilly MM, Mummery C, Brandner S, Hirsch N, Lunn MP. Rituximab in the treatment of three coexistent neurological autoimmune diseases: chronic inflammatory demyelinating polyradiculoneuropathy, Morvan syndrome and myasthenia gravis. J Neurol Neurosurg Psychiatry. 2011; 82: 230-232.
6. Diaz-Manera J, Rojas-Garcia R, Gallardo E, Juarez C, Martinez-Domeno A, Martinez-Ramirez S, et al. Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan's syndrome. Nat Clin Pract Neurol 2007; 3: 405-410.
7. Iwasaki Y, Kinoshita M, Ikeda K, Takamiya K, Shiojima T. Concurrence of myasthenia gravis and chorée fibrillaire de Morvan. Eur Arch Psychiatry Neurol Sci 1990; 239: 335-336.
8. Thieben MJ, Lennon VA, Boeve BF, Aksamit AJ, Keegan M, Vernino S. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology 2004; 62: 1177-1182.
9. Antozzi C, Frassoni C, Vincent A, Regondi MC, Andreetta F, Bernasconi P, et al. Sequential antibodies to potassium channels and glutamic acid decarboxylase in neuromyotonia. Neurology 2005; 64: 1290-1293.